Respiratory

19 source-linked study cards in this body system.

Albuterol
Fluticasone
Montelukast
Benzonatate
Fluticasone Propionate / Salmeterol
Budesonide / Formoterol
Fluticasone propionate
Fluticasone furoate / Umeclidinium / VilanterolTrelegy Ellipta
Promethazine / Dextromethorphan
Guaifenesin / Codeine
Budesonide (inhalation suspension)
Ipratropium / Albuterol
Tiotropium bromide (soft mist inhaler)Spiriva
Fluticasone furoate / Vilanterol
Brompheniramine / Pseudoephedrine / Dextromethorphan
Ipratropium Bromide
Guaifenesin
Mometasone Furoate
Dextromethorphan / Guaifenesin

How each medicine works

Medicines in this body system: 19

Albuterol — Activates beta-2 receptors on airway smooth muscle, raising cyclic AMP via adenylcyclase and relaxing bronchial smooth muscle.
Fluticasone — A synthetic trifluorinated corticosteroid with anti-inflammatory activity. High glucocorticoid-receptor binding affinity is shown in vitro, but its clinical significance and the precise mechanism of rhinitis symptom relief are unknown.
Montelukast — Binds with high affinity and selectivity to the CysLT1 receptor, inhibiting physiologic actions of leukotriene D4 in the airway.
Benzonatate — Anesthetizes stretch receptors in the airways, lungs and pleura, damping the cough reflex at its source.
Fluticasone Propionate / Salmeterol — Fluticasone: synthetic corticosteroid with anti-inflammatory activity; salmeterol: long-acting beta2-agonist bronchodilator.
Budesonide / Formoterol — Budesonide: potent glucocorticoid anti-inflammatory; formoterol: long-acting selective beta2-agonist bronchodilator.
Fluticasone propionate — A synthetic trifluorinated corticosteroid with anti-inflammatory activity and high glucocorticoid-receptor affinity in vitro. It affects inflammatory cells and mediators, but the precise mechanism of rhinitis symptom relief and the clinical significance of receptor-binding findings are unknown.
Fluticasone furoate / Umeclidinium / Vilanterol — Fluticasone furoate: anti-inflammatory corticosteroid. Umeclidinium: long-acting muscarinic antagonist. Vilanterol: long-acting beta2 agonist.
Promethazine / Dextromethorphan — Promethazine: H1 receptor blocker with sedative and antiemetic effects. Dextromethorphan: acts centrally to raise the cough threshold.
Guaifenesin / Codeine — Expectorant action loosens phlegm and thins bronchial secretions to make cough more productive; product also relieves cough.
Budesonide (inhalation suspension) — Anti-inflammatory corticosteroid with potent glucocorticoid and weak mineralocorticoid activity.
Ipratropium / Albuterol — Ipratropium blocks muscarinic acetylcholine receptors; albuterol stimulates beta2 receptors, raising cAMP and relaxing airway muscle.
Tiotropium bromide (soft mist inhaler) — Long-acting antimuscarinic; inhibits M3 receptors on airway smooth muscle, causing bronchodilation.
Fluticasone furoate / Vilanterol — Fluticasone furoate: anti-inflammatory corticosteroid. Vilanterol: long-acting beta2-adrenergic agonist (LABA).
Brompheniramine / Pseudoephedrine / Dextromethorphan — Brompheniramine: alkylamine H1 blocker with anticholinergic effects. Pseudoephedrine: alpha-adrenergic nasal decongestant. Dextromethorphan: raises the cough threshold.
Ipratropium Bromide — Anticholinergic; applied locally, inhibits secretions from serous and seromucous nasal glands.
Guaifenesin — Expectorant; loosens phlegm and thins bronchial secretions.
Mometasone Furoate — Corticosteroid with potent anti-inflammatory effects on mast cells, eosinophils, and mediators; exact mechanism in rhinitis unknown.
Dextromethorphan / Guaifenesin — Guaifenesin loosens phlegm and thins bronchial secretions; dextromethorphan temporarily relieves cough.

Each summary is the mechanism line from the medicine’s study card.

Listed most often on cards in this body system

Common side effects

Headache · 11/19: Albuterol, Fluticasone, Montelukast, Benzonatate, Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Fluticasone propionate, Fluticasone furoate / Umeclidinium / Vilanterol, Tiotropium bromide (soft mist inhaler), Fluticasone furoate / Vilanterol (+1)

Pharyngitis · 8/19: Albuterol, Fluticasone, Montelukast, Fluticasone Propionate / Salmeterol, Fluticasone propionate, Ipratropium / Albuterol, Tiotropium bromide (soft mist inhaler), Mometasone Furoate (nasal)

Cough · 5/19: Fluticasone, Montelukast, Fluticasone propionate, Tiotropium bromide (soft mist inhaler), Mometasone Furoate (nasal)

Dizziness · 4/19: Albuterol, Benzonatate, Promethazine / Dextromethorphan, Brompheniramine / Pseudoephedrine / Dextromethorphan

Epistaxis · 4/19: Fluticasone, Fluticasone propionate, Ipratropium Bromide, Mometasone Furoate (nasal)

Upper respiratory tract infection · 4/19: Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Fluticasone furoate / Umeclidinium / Vilanterol, Fluticasone furoate / Vilanterol

Oral candidiasis · 4/19: Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Fluticasone furoate / Umeclidinium / Vilanterol, Fluticasone furoate / Vilanterol

Sedation · 3/19: Benzonatate, Promethazine / Dextromethorphan, Brompheniramine / Pseudoephedrine / Dextromethorphan

Warnings

Glaucoma and cataracts · 3/19: Fluticasone, Fluticasone propionate, Mometasone Furoate (nasal)

Not for acute bronchospasm · 3/19: Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Budesonide (inhalation suspension)

Interactions

Beta-blockers · 6/19: Albuterol, Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Fluticasone furoate / Umeclidinium / Vilanterol, Ipratropium / Albuterol, Fluticasone furoate / Vilanterol

Strong CYP3A4 inhibitors · 4/19: Fluticasone Propionate / Salmeterol, Budesonide / Formoterol, Fluticasone furoate / Umeclidinium / Vilanterol, Fluticasone furoate / Vilanterol

Boxed warning

2/19: Montelukast, Promethazine / Dextromethorphan

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.